METTL3 may affect the prognosis of BC by regulating the level of immune infiltration, suggesting that METTL3 is an immune-related biomarker for bladder cancer and may become an indicator for early diagnosis in the future (19). The gene discussed is METTL3; the disease is urinary bladder carcinoma.